Background {#Sec1}
==========

Coronary artery disease (CAD) is relatively rare in patients \< 40 years of age, occurring in 6--10% of all patients \< 40 years of age; however, there has recently been an increase in incidence \[[@CR1], [@CR2]\]. A variety of risk factors are known to be involved in the onset and progression of CAD \[[@CR3]\], the contributions of which vary in patients of different ages. Cigarette smoking has been shown to be a major cause of premature CAD. Several studies have described the relationship between hyperuricemia (HUA) and CAD in middle-aged and elderly populations \[[@CR4], [@CR5]\]. These studies have shown that HUA may play a role in CAD; however, due to the relatively low prevalence of CAD in young adults, the association between HUA and CAD in young adults has not elicited attention among the public.

Given the oxidative and inflammatory-induced properties of HUA and cigarrete smoking, along with the associations with risk for CAD, investigating the effect of the interaction between HUA and current smokers on premature CAD is warranted.

Thus, the current study was designed to determine the following: 1) association between HUA and CAD; 2) association between cigarette smoking and CAD; 3) interactive effect of both factors on the risk for CAD in young adults ≤ 35 years of age; and 4) the association between HUA and cigarrete smoking in the study participants.

Methods {#Sec2}
=======

Study population {#Sec3}
----------------

In this observational study, young adults suspected to have CAD (18--35 years of age) who underwent coronary angiography for the first time at Anzhen Hospital between January 2005 and December 2015 were consecutively enrolled. Our study was approved by the Institutional Ethics Committee at Beijing Anzhen Hospital. Written informed consent was gained from all participants. The exclusion criteria were as follows: 1. gout, heart failure, renal impairment (an estimated glomerular filtration rate \[eGFR\] \< 60 mL/minute per 1.73 m^2^), inflammatory diseases, autoimmune diseases (Takayasu's arteritis, infective endocarditis, and rheumatic heart disease), and missing uric acid data; 2. medication history prior to admission, including diuretics or anti-hypertension drugs, losartan and hydrochlorothiazide tablets, compound amiloride hydrochloride tablets, irbesartan, and hydrochlorothiazide, which are known to affect the level of uric acid; 3. previous percutaneous coronary intervention or coronary artery bypass grafting in our institution; and 4. congenital heart disease, cardiomyopathy, and valvular heart disease.

Ascertainment of outcome {#Sec4}
------------------------

Coronary angiography was performed using a standardized technique. Coronary angiogram results were affirmed by two experienced cardiologists. Major epicardial coronary arteries, including the left main, left anterior descending, left circumflex, right coronary artery, and the vessels' main branches, were evaluated, and a luminal diameter stenosis ≥50% in any of the vessels above was defined as CAD. Patients with a history of an acute myocardial infarction were also considered to have CAD.

Definition and collection of variables {#Sec5}
--------------------------------------

Based on published clinical guidelines, HUA was defined as a serum uric acid (SUA) level ≥ 7.0 mg/dl (420 mmol / L) in males and ≥ 6.0 mg / dl (357 mmol/L) in females \[[@CR6]\]. Hypertension was defined as a blood pressure ≥ 140/90 mmHg or using anti-hypertension medications \[[@CR7]\]. Diabetes mellitus was defined according to the WHO diabetes diagnostic criteria in 1999. LDL-C ≥ 130 mg/dl (3.4 mmol / L) was considered to be a high LDL-C level, TG ≥ 150 mg/dl (1.7 mmol / L) was considered to be hypertriglyceridemia, HDL-C \< 40 mg/dl (1.0 mmol / L) was considered to be a low HDL-C level, and TC ≥ 200 mg/dl (5.2 mmol / L) was considered to be hypercholesterolemia \[[@CR8]\].

SUA was analyzed on a Beckmann AU54 automated biochemical analyzer (Beijing, China) using a uric acid commercial kit (uricase-peroxidase method).

Personal histories of hypertension, diabetes mellitus, a family history of CAD, cigarette smoking, and alcohol consumption were collected from electronic medical records.

Statistical analyses {#Sec6}
--------------------

Continuous variables are presented as the mean ± standard deviation and compared using an unpaired t-test for normally distributed data or as the median with interquartile range and compared using a Mann-Whitney U test for non-normally distributed data. Categorical variables are presented as frequencies or percentages and compared using a chi-square test. Univariate analysis was performed, then covariates with a *p* \< 0.05 on the univariate analysis were analyzed for collinearity. The variables were then selected and added to a multivariable analysis. The relationship between HUA, cigarrete smoking, and the presence of CAD was evaluated with multivariate logistic regression analysis. A *p* value ≤0.05 (two-sided) was considered statistically significant. We tested for interactions between uric acid (HUA or normouricemia) and cigarrete smoking on the risk for CAD. A *p*-value for interaction was measured using the log likelihood ratio test to determine if there was a significant difference between the following two regression models: 1. a complex regression model including not only the exposure and confounding factors, but also the interaction terms of each of the factors with the effect modifier; and 2. a simple model without the interaction terms. With a *p*-value for interaction \< 0.05, there was a significant difference between the two models, indicating that the complex model interpreted the data better. All analyses were performed with the statistical software package R and EmpowerStats (<http://www.empowerstats.com>; X&Y Solutions, Inc., Boston, MA, USA) \[[@CR9]\].

Results {#Sec7}
=======

Patient demographics {#Sec8}
--------------------

A total of 1113 participants fulfilling the criteria were enrolled in this observational study. The mean age was 31.8 years and 93.7% of the participants were male. Additional file [1](#MOESM1){ref-type="media"}: Figure S1 shows the flow chart of the study. The 771 participants with ≥50% major cardiac artery narrowing and a history of an acute myocardial infarction made up the CAD group, and the remaining 342 participants comprised the non-CAD group. The baseline characteristics are shown in Table [1](#Tab1){ref-type="table"}. Current smokers and hypertriglyceridemia were more prevalent in the CAD group than the non-CAD group (68.2% vs. 57.4% and 60.6% vs. 47.8%, respectively; *P*\<0.001). The CAD group also had a decreased level of HDL-C (*P*\<0.001). Moreover, a greater percentage of patients with HUA were in the CAD group (*p* = 0.034). In the CAD group, 21.6% of patients were treated with drugs.Table 1Baseline clinical characteristics in Non-CAD and CAD patientsBaseline CharacteristicsNon-CAD groupCAD group*p* value(*n* = 342)(*n* = 771)Age (years)32.1 ± 3.031.6 ± 3.40.033Male, n (%)318 (92.2)730 (94.4)0.149Hyperuricemia, n (%)104 (30.4)285 (37.0)0.034Alcohol drinking, n (%)86 (24.9)194 (25.1)0.952BUN(mg/dL)14.2 ± 7.812.4 ± 4.8\< 0.001Serum creatinine(mg/dL)0.9 ± 0.20.9 ± 0.20.278Triglycerides(mg/dL)145.3 (102.8--218.8)172.8(118.1--250.5)\< 0.001HDL-C(mg/dL)38.1 ± 9.235.0 ± 8.0\< 0.001LDL-C (mg/dL)109.0 ± 32.3114.7 ± 46.80.043Total cholesterol (mg/dL)173.4 ± 41.7179.2 ± 55.50.084Uric acid (mg/dL)6.4 ± 1.66.6 ± 1.60.194Fasting glucose (mg/dL)96.8 ± 26.3104.3 ± 33.0\< 0.001BMI(kg/m^2^)26.8 ± 4.227.9 ± 4.1\< 0.001Traditional coronary risk factor, n (%)Current smokers, n (%)198 (57.4)527 (68.2)\< 0.001Family history of CAD, n (%)33 (9.6)113 (14.6)0.021Hypertension, n (%)135 (39.1)324 (41.9)0.382Diabetes mellitus, n (%)32 (9.3)124 (16.0)0.003Metabolic syndrome, n (%)168 (49.4)450 (58.9)0.003Hypercholesterolemia, n (%)74 (21.7)208 (27.2)0.055Hypertriglyceridemia, n (%)163 (47.8)464 (60.6)\< 0.001High LDL-C, n (%)83 (24.3)207 (27.0)0.349Low HDL-C, n (%)235 (68.9)586 (76.5)0.008familial hypercholesterolemia, n (%)0 (0.0)12 (1.6)0.020Treatment, n (%)\< 0.001Drugs, n (%)11 (3.2)167 (21.6)Intervention, n (%)0 (0.0)528 (68.3)CABG, n (%)0 (0.0)77 (10.0)Aspirin, n (%)162 (47.0)742 (96.0)\< 0.001Clopidogrel/ticagrelor, n (%)48 (13.9)639 (82.7)\< 0.001Statin, n (%)142 (41.2)743 (96.1)\< 0.001β-blocker, n (%)103 (29.9)630 (81.5)\< 0.001Values are given as mean ± standard deviation,medians with interquartile range or number (%)Abbreviations: *BUN* blood urea nitrogen, *HDL-C* high density lipoprotein cholesterol, *LDL-C* low density lipoprotein cholesterol, *BMI* body mass index, *CAD* coronary artery disease

Univariate analysis of different CAD risk factors {#Sec9}
-------------------------------------------------

Univariate analysis showed that the traditional CAD risk factors for cigarette smoking, BMI, family history of CAD, hypertriglyceridemia, low level of HDL-C, metabolic syndrome, and diabetes mellitus were significantly associated with the presence of CAD (P\<0.05). In contrast, the risk factors for hypertension and hypercholesterolemia were not significantly related to CAD(Table [2](#Tab2){ref-type="table"}). Within the entire patient group, univariate analysis revealed that HUA was significantly associated with the occurrence of CAD (OR, 1.34; 95% CI, 1.02--1.76; *p* = 0.035; Table [2](#Tab2){ref-type="table"}).Table 2Univariate analysis of CAD risk factorsVariablesMean ± SDn (%)Crude HR (95% CI)*p* valueAge31.8 ± 3.30.96 (0.92, 1.00)0.034Gender Male1043 (93.7)1.45 (0.88, 2.39)0.144 Female70 (6.3)1.0Hyperuricemia Yes389 (34.95)1.34 (1.02, 1.76)0.035 No724 (65.05)1.0BUN12.9 ± 5.90.95 (0.93, 0.97)\< 0.001Serum creatinine0.9 ± 0.21.51 (0.72, 3.19)0.278BMI27.6 ± 4.21.06 (1.03, 1.10)\< 0.001Alcohol drinking Yes280 (25.2)1.00 (0.75, 1.34)0.996 No833 (74.8)1.0Current smokersYes724 (65.0)1.56 (1.20, 2.03)\< 0.001No389 (35.0)1.0Family history of CAD Yes146 (13.1)1.61 (1.07, 2.42)0.023 No967 (86.9)1.0Hypertension Yes456 (41.0)1.11 (0.86, 1.44)0.419 No657 (59.0)1.0Diabetes mellitus Yes156 (14.0)1.86 (1.23, 2.80)0.003 No957 (86.0)1.0Metabolic syndrome Yes618 (56.0)1.47 (1.13, 1.90)0.003 No486 (44.0)1.0Total cholesterol TC \> =200282 (25.5)1.34 (0.99, 1.82)0.055 TC \< 200825 (74.5)1.0Triglycerides TG \> =150627 (56.6)1.68 (1.30, 2.17)\< 0.001 TG \< 150480 (43.4)1.0LDL-C LDL-C \> =130290 (26.2)1.15 (0.86, 1.54)0.349 LDL-C \< 130817 (73.8)1.0HDL-C HDL-C \< 40821 (74.2)1.47 (1.11, 1.95)0.008 HDL-C \> =40286 (25.8)1.0Abbreviations: *BUN* blood urea nitrogen, *HDL-C* high density lipoprotein cholesterol, *LDL-C* low density lipoprotein cholesterol, *BMI* body mass index, *CAD* coronary artery disease

Multivariate logistic regression analysis model of different traditional CAD risk factors {#Sec10}
-----------------------------------------------------------------------------------------

Logistic regression analysis further indicated that the traditional CAD risk factors, such as cigarette smoking, diabetes mellitus, and hypertriglyceridemia, had significant associations with the presence of CAD (*P*\<0.05; Fig. [1](#Fig1){ref-type="fig"}).Fig. 1Forest plot of Multi-variate logistic regression analysis model of different CAD risk factors. Logistic regression analysis indicated that cigarrete smoking, diabetes mellitus and hypertriglyceridemia had significant associations with the presence of CAD. Hyperuricemia, BMI, family history of CAD, high LDL-C level, low HDL-C level, hypercholesterolemia and hypertension were not associated with the occurrence of CAD. The factors that were related to the dependent variables mentioned in previous studies enter into the univariate analysis. Covariates with *p* \< 0.05 in the univariate analysis were analyzed for collinearity. Afterwards, the variables selected finally were added to the full models. Abbreviations: HDL-C = high density lipoprotein cholesterol; LDL-C = low density lipoprotein cholesterol; BMI = body mass index; CAD = coronary artery disease

Multivariate logistic regression analysis of HUA on CAD {#Sec11}
-------------------------------------------------------

In addition, the association between HUA and the occurrence of CAD differed between groups. Multivariate logistic analysis showed that after adjusting for age, high LDL-C, low HDL-C, hypercholesterolemia, hypertriglyceridemia, metabolic syndrome, BMI, hypertension, diabetes mellitus, and a family history of CAD, HUA was significantly associated with the occurrence of CAD in the subgroup of non-smokers (OR, 1.84; 95% CI, 1.03--3.29), but the association did not exist in the current smokers sub-group (OR, 0.93; 95% CI, 0.64--1.35; Table [3](#Tab3){ref-type="table"}). Figure [2](#Fig2){ref-type="fig"} shows the logistic association between HUA and the presence of CAD in the non-smoker (*p* = 0.039) and current smoker groups (*p* = 0.69).Table 3Association between hyperuricemia and CAD in different subgroups of smokers and non-smokersVariablesNo. of patientsOdds Ratio (95% CI)CrudeModel I^a^Non-Smokers Normouricemia279ReferenceReference Hyperuricemia1102.08 (1.28, 3.40)1.84 (1.03, 3.29)Current smokers Normouricemia445ReferenceReference Hyperuricemia2791.01 (0.72, 1.41)0.93 (0.64, 1.35)Abbreviations: *CAD* coronary artery disease, *HDL-C* high density lipoprotein cholesterol, *LDL-C* low density lipoprotein cholesterol, *BMI* body mass index, *CI* confidence interval, *OR* odds ratio^a^Adjusted for Age, High LDL-C, Low HDL-C, Hypercholesterolemia, Hypertriglyceridemia, Metabolic syndrome, BMI, Hypertension, Diabetes mellitus, Family history of CAD, Blood urea nitrogen, Serum creatinine and Alcohol drinkingFig. 2The association of hyperuricemia and the presence of CAD according to cigarrete smoking in Multi-variate logistic regression analysis. Abbreviations: CI = confidence interval; OR = odds ratio; CAD = coronary artery disease

Interaction effect of HUA and cigarrete smoking on the risk of CAD {#Sec12}
------------------------------------------------------------------

We further found that the interaction between HUA and cigarrete smoking achieved statistical significance for the occurrence of CAD (*p* = 0.008; Additional file [1](#MOESM1){ref-type="media"}: Table S1).

Relationship between HUA and cigarrete smoking in the study population {#Sec13}
----------------------------------------------------------------------

Moreover, we found more subjects with HUA among the current smokers (*p* \< 0.001), and the current smoker group had higher levels of plasma uric acid than the non-smoker group (*p* \< 0.001), both in males (*p* = 0.009) and females (*p* = 0.019; Additional file [1](#MOESM1){ref-type="media"}: Table S2).

Discussion {#Sec14}
==========

HUA and CAD {#Sec15}
-----------

In this observational study, we confirmed that HUA was significantly associated with incident CAD in non-smokers ≤ 35 years of age.

Previous studies have also reported a relationship between HUA and CAD \[[@CR4], [@CR10]--[@CR12]\]. Some of the results confirmed a strong association between HUA and CAD; however, most of the results focused on the relationship between HUA and the risk of CAD in a middle-aged and elderly population \[[@CR11], [@CR13]\]. The reports did not focus on the relationship between HUA and CAD in young adults. A study involving a population with an average age of 40 ± 4 years suggested that SUA levels were independently related to coronary calcifications (indicators of sub-clinical coronary atherosclerosis). The recent study concerning on the relationship between HUA and CAD in patients ≤35 years of age (the 2015 CARDIA study) showed that after adjusting for demographic and lifestyle factors, the baseline SUA concentration was positively associated with the prevalence of CVD (HR, 1.21; 95% CI, 1.05--1.39; *p* = 0.005). This positive association was not significant in the full model due to the simultaneous effects of traditional risk factors (HR, 1.09; 95% CI, 0.94--1.27; *p* = 0.24) \[[@CR14]\]. This conclusion was similar to our findings. Compared with the above studies, our study had access to a wide range of covariates and minimized the residual confounding, and still demonstrated a strong association.

Role of cigarette smoking {#Sec16}
-------------------------

We stratified our patients into smokers versus non-smokers and found that the association between HUA and the presence of CAD existed in non-smokers only. In current smokers, we did not find a strong association between HUA and the presence of CAD, considering the stronger effect of cigarette smoking on young patients with CAD and the unbalanced gender ratio in the participants.

In addition, we identified more subjects with HUA among current smokers. The reasons for the increase in SUA levels in current smokers group may include the following: 1. Increasing SUA reabsorption. Studies have shown that smoking is positively correlated with the degree of insulin resistance, \[[@CR15]\] and insulin resistance promotes sodium-hydrogen exchange in the renal proximal tubules \[[@CR13]\]. With the increase in sodium-hydrogen exchange, anions, including uric acid, increase \[[@CR16]\]. 2. Reducing the SUA excretion. Cigarettes contain a variety of harmful substances, including oxidants and free radicals that can result in a cytotoxic effect and lead to renal damage, thus eventually reducing the excretion of uric acid \[[@CR17], [@CR18]\]. A 2011 study of SUA and cigarette smoking among 300 volunteers 19.6--55.5 years of age showed a reduction in SUA levels in the smoking group \[[@CR19]\]. These results were not consistent with our results, considering the differences in the age and the health status of the study participants, which need further study.

The current results can only explain the possible existence of the interaction between HUA and cigarette smoking on CAD, and the specific pathways need more in-depth research.

The clinical importance of this article is that for young adults, in addition to the main risk factors for premature CAD, such as cigarette smoking, non-traditional risk factors, such as HUA plays an important role in the occurrence of premature CAD. A young non-smoking population, from the perspective of coronary heart disease prevention, should pay more attention to the adverse effects of metabolic diseases, such as HUA and obesity, and improve eating habits to maintain a uric acid at normal levels.

Study limitations {#Sec17}
-----------------

There were several limitations to this study. First, the participants in the control group included some sub-health groups. If the participants in the control group were thoroughly healthy, the effect of HUA on CAD would be more prominent. Second, most of our participants were high-risk groups of cardiovascular disease. Thus, the positive rate of coronary angiography was high. These populations may not represent the general population. Third, the effect of anti-HUA drugs on the progression of CAD should be investigated further in large randomized trials, which may potentially provide new therapeutic approaches for the prevention and treatment of CAD.

Conclusions {#Sec18}
===========

In our study, HUA was shown to be significantly associated with the presence of CAD in non-smokers ≤ 35 years of age.

Additional file
===============

 {#Sec19}

Additional file 1:**Table S1.** Interaction effect of hyperuricemia and cigarrete smoking on CAD. **Table S2.** Relationship between hyperuricemia/uric acid and smoking in the special group. **Figure S1.** Flowchart of the study. (DOCX 546 kb)
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